Smrithi Rajendiran
Affiliations: | University of California, Santa Cruz, Santa Cruz, CA, United States |
Google:
"Smrithi Rajendiran"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rodriguez Y Baena A, Rajendiran S, Manso BA, et al. (2022) New transgenic mouse models enabling pan-hematopoietic or selective hematopoietic stem cell depletion in vivo. Scientific Reports. 12: 3156 |
| Rajendiran S, Boyer SW, Forsberg EC. (2020) A quantitative hematopoietic stem cell reconstitution protocol: Accounting for recipient variability, tissue distribution and cell half-lives. Stem Cell Research. 50: 102145 |
| Rajendiran S, Smith-Berdan S, Kunz L, et al. (2020) Ubiquitous overexpression of CXCL12 confers radiation protection and enhances mobilization of hematopoietic stem and progenitor cells. Stem Cells (Dayton, Ohio) |
| Smith-Berdan S, Bercasio A, Rajendiran S, et al. (2019) Viagra Enables Efficient, Single-Day Hematopoietic Stem Cell Mobilization. Stem Cell Reports |
| Boyer SW, Rajendiran S, Beaudin AE, et al. (2019) Clonal and Quantitative In Vivo Assessment of Hematopoietic Stem Cell Differentiation Reveals Strong Erythroid Potential of Multipotent Cells. Stem Cell Reports |
| Rajendiran S, Boyer S, Beaudin A, et al. (2018) In Vivo Lineage Potential of Hematopoietic Stem and Progenitor Cells Using a Novel Quantification Method Suggests an Erythroid-Favored Differentiation Model Experimental Hematology. 64: S51 |
| Kpetemey M, Dasgupta S, Rajendiran S, et al. (2015) MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Molecular Cancer. 14: 156 |
| Rajendiran S, Kpetemey M, Maji S, et al. (2015) MIEN1 promotes oral cancer progression and implicates poor overall survival. Cancer Biology & Therapy. 16: 876-85 |